These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9349518)

  • 1. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides.
    Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC
    Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization.
    Johnson TM; Kuffel DG; Dewald GW
    Mayo Clin Proc; 1996 Jul; 71(7):643-8. PubMed ID: 8656705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
    Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
    J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
    Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
    Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
    Nieh S; Chen SF; Fu E; Jan CI; Lee WH
    Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions.
    Rosolen DC; Kulikowski LD; Bottura G; Nascimento AM; Acencio M; Teixeira L; Vargas FS; Sales RK; Antonangelo L
    Lung Cancer; 2013 Jun; 80(3):284-8. PubMed ID: 23453645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
    J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).
    Fiegl M; Massoner A; Haun M; Sturm W; Kaufmann H; Hack R; Krugmann J; Fritzer-Szekeres M; Grünewald K; Gastl G
    Br J Cancer; 2004 Aug; 91(3):558-63. PubMed ID: 15226776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
    Zojer N; Fiegl M; Angerler J; Müllauer L; Gsur A; Roka S; Pecherstorfer M; Huber H; Drach J
    Br J Cancer; 1997; 75(3):403-7. PubMed ID: 9020486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
    Savic S; Franco N; Grilli B; Barascud Ade V; Herzog M; Bode B; Loosli H; Spieler P; Schönegg R; Zlobec I; Clark DP; Herman JG; Bubendorf L
    Chest; 2010 Jul; 138(1):137-44. PubMed ID: 20139227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.
    Walts AE; Hiroshima K; McGregor SM; Wu D; Husain AN; Marchevsky AM
    Diagn Cytopathol; 2016 Jul; 44(7):599-606. PubMed ID: 27121152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH).
    Fiegl M; Zojer N; Kaufmann H; Müllauer L; Schuster R; Huber H; Drach J
    Cytometry; 1999 Feb; 38(1):15-23. PubMed ID: 10088972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions].
    Yang JJ; Xu XX; Min LF; Lin P; Qian GS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
    Lv M; Cha N; Zou YF; Leng JH; Hao YY; Wang S
    Diagn Cytopathol; 2021 Jul; 49(7):811-816. PubMed ID: 33818924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
    Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
    Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.